Company news

Novamind Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

CSE Bulletin: Delist -Novamind Inc. (NM)

June 13, 2022

Novamind Obtains Final Order for Plan of Arrangement from the Supreme Court of British Columbia and Completes Acquisition by Numinus Wellness Inc.

June 10, 2022

Novamind Shareholders Approve Proposed Acquisition by Numinus

June 8, 2022

Novamind Announces New Patient Financing Options

June 2, 2022

Novamind Reports Fiscal Q3 2022 Financial Results and Operating Highlights

May 31, 2022

Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders of Novamind Vote FOR the Proposed Plan of Arrangement

May 27, 2022

Novamind Launches Group Psychedelic Treatment for Frontline Workers

May 19, 2022

Novamind Files Management Information Circular for Special Meeting of Shareholders and Announces Receipt of Interim Court Order for Plan of Arrangement

May 11, 2022

Novamind to Host Bionomics' PREVAIL Trial for Acute Treatment of Social Anxiety Disorder

May 10, 2022

Novamind Announces Virtual Group Health Coaching

May 2, 2022

Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

April 12, 2022

Novamind Opens 8th Integrative Psychiatry Clinic

April 6, 2022

Novamind Partner to Acquire Specialized Ibogaine Group in Brazil

March 31, 2022

Novamind Expands Group Therapy Model

March 24, 2022

Novamind to Host MindMed Phase IIb Trial for LSD and Anxiety

March 16, 2022

Novamind Grants Restricted Share Units

March 11, 2022

Novamind to Conduct Phase II Psilocybin Trial for Major Depressive Disorder

March 9, 2022

Novamind Reports Fiscal Q2 2022 Financial Results and Operating Highlights

March 1, 2022

Novamind Publishes Psychedelic Therapy Patient Case Studies

February 22, 2022

Novamind Advances Clinical Pilot for Frontline KAP

February 16, 2022

Novamind Participates in Alto Neuroscience Phase II Clinical Trial for MDD and PTSD

February 9, 2022

Novamind Appoints Prakash Gowd as Chief Operating Officer

February 8, 2022

Novamind Hosts Clinical Trial to Advance Ketamine Therapy for End-of-Life Patients

February 3, 2022

Novamind Announces Closing of CAD$5 Million Private Placement with Institutional Investor

January 25, 2022

Novamind Announces CAD$5 Million Private Placement with Institutional Investor

January 24, 2022

Novamind to Participate in Citi's Psychedelic Drug Video Call Series

January 20, 2022

Novamind Closes Arizona Acquisition

January 18, 2022

Novamind Hosts Pioneering Psychedelic Clinical Trial for Opioid Use Disorder

January 13, 2022

Novamind Unveils New Design Concept for Clinics

January 5, 2022

Novamind Signs Definitive Agreement to Acquire Arizona-based Clinics

December 23, 2021

Novamind Opens New Clinic with Specialized Focus on Substance Use Disorders

December 6, 2021

Novamind to Present at the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6

December 2, 2021

Novamind Partners with Uruguay-Based Bienstar Wellness to Develop Latin America's First Integrative Mental Health Clinic Network

December 1, 2021

Novamind Reports Fiscal Q1 Financial Results and Operating Highlights

November 29, 2021

Novamind Unveils New Logo and Invests in Unified Brand

November 24, 2021

Novamind Signs LOI to Acquire Two Mental Health Clinics in Arizona

November 16, 2021

Novamind to Present at International Summit on Psychedelic Therapies for Mental Illness

November 15, 2021

Novamind Enters New Lease Agreement Responding to Patient Demand

November 12, 2021

Novamind Secures Insurance Coverage for Ketamine from Four Major Payors

November 10, 2021

Novamind Announces Revocation of Cease Trade Order and Reinstatement of Trading

November 8, 2021

CSE Bulletin: Reinstatement - Novamind Inc. (NM)

November 8, 2021

Novamind Reports FY2021 Financial Results and Operating Highlights

November 5, 2021

CSE Bulletin: Suspensions (MMI, CNFA, VPN, NM, EXM)

November 4, 2021

Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements

November 4, 2021

Novamind Unveils Stealth Mode Investment in Alto Neuroscience

October 22, 2021

Novamind Granted DEA Licenses for Psilocybin Research

October 13, 2021

Novamind to Present at LD Micro and KCSA Conferences

October 8, 2021

Novamind Launches New Psychedelic Palliative Care Program

October 7, 2021

Novamind to Deliver Keynote at PSYCH Investor Summit on October 7, 2021

October 4, 2021

Novamind Opens 6th Integrative Psychiatry Clinic, Adds 3rd Clinical Research Site

September 30, 2021

Older news releases →

Decks